跳至主要内容
临床试验/ACTRN12606000244505
ACTRN12606000244505终止4 期

An open label study to assess the efficacy of Travelan as an adjunct therapy to reduce inflammation in Ulcerative Colitis

Anadis Ltd0 个研究点目标入组 20 人开始时间: 2006年6月19日最近更新:
适应症

试验速览

阶段
4 期
状态
终止
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Mild to moderate ulcerative colitis (UC)* diagnosed with UC at least 12 months previously* diagnosis on clinical grounds confirmed by colonoscopy within last 2 years* UC with a modified Mayo score >4.

排除标准

  • Severe ulcerative colitis* any major gastrointestinal surgery* partial bowel obstruction* patients with co-existing non-intestinal inflammatory disease (eg disease assoc with elevated ESR)* pregnancy or breast feeding* alcohol or drug abuse* smoker* significant allergy to cow's milk* insistence on maintaining Probiotic intake during study* treated with oral steroids within 2 weeks of commencing screening.

研究者

发起方
Anadis Ltd

相似试验